Brief: Dynavax Technologies Q4 EPS USD 0.06
20/02/2025 21:01
Feb 20 (Reuters) - Dynavax Technologies Q4 operating income USD -1.632 million. * Q4 net income USD 7.05 million * Q4 pretax profit USD 7.629 million * Q4 operating expenses USD 73.664 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality